All Stories

  1. Integrating hypertriglyceridemia, inflammation, and β-cell stress in clozapine- and olanzapine-associated pancreatitis

    Article • Journal of Affective Disorders, November 2026, Elsevier

    Takahiko Nagamine

  2. A two-speed β-cell failure model for diabetes in non-obese Asian patients with schizophrenia

    Article • Asian Journal of Psychiatry, August 2026, Elsevier

    Takahiko Nagamine

  3. Beyond fatality signals: Reconsidering clozapine safety through severe gastrointestinal hypomotility and real-world clinical complexity

    Article • Asian Journal of Psychiatry, August 2026, Elsevier

    Takahiko Nagamine

  4. Brain-heart axis in burning mouth syndrome: a neurobiological perspective

    Article • The Korean Journal of Pain, June 2026, Korean Pain Society (KAMJE)

    Takahiko Nagamine

  5. Sensory Blurring in Nociplastic Pain: The Role of Descending Inhibitory Dysfunction and Gut–Brain Axis Alterations in Older Adults

    Article • Geriatrics, June 2026, MDPI AG

    Takahiko Nagamine

  6. Optimizing Management of Treatment‐Resistant Schizophrenia in Japan: Promoting a Refined Clozapine Titration Protocol and Addressing the ‘Clozapine Ceiling’ through Glutamatergic Modulation

    Article • Psychiatry and Clinical Neurosciences, June 2026, Wiley

    Takahiko Nagamine

  7. Differentiating Trigeminal Neuralgia From Persistent Idiopathic Dentoalveolar Pain and Persistent Idiopathic Facial Pain in Oral and Maxillofacial Surgery

    Article • Journal of Oral and Maxillofacial Surgery, June 2026, Elsevier

    Takahiko Nagamine

  8. Loneliness as a Relational Barometer: A Dyadic Perspective on Caregiver Burden

    Article • Geriatrics and Gerontology International, May 2026, Wiley

    Takahiko Nagamine

  9. Pharmacological Incongruity of Lacosamide in the Management of Delirium Complicated by Ileus

    Article • Neuropsychopharmacology Reports, May 2026, Wiley

    Takahiko Nagamine

  10. Brain-Heart Axis in Burning Mouth Syndrome: A Neurobiological Framework

    Article • Clinical and Molecular Epidemiology, May 2026, Innovation Forever Publishing Group Limited

    Takahiko Nagamine

  11. The Contralateral Muscle Reserve: Rethinking Post‐Operative Risk Stratification and Discharge Trajectories in Acute Hip Fracture Care

    Article • Geriatrics and Gerontology International, May 2026, Wiley

    Takahiko Nagamine

  12. The Gut–Muscle Axis in Sarcopenia: From Parallel Aging to a Self‐Perpetuating Vicious Cycle

    Article • Geriatrics and Gerontology International, May 2026, Wiley

    Takahiko Nagamine

  13. Methodological Limitations and the Necessity of Objective Biomarkers in Linking Oral Frailty to Subjective Sleep Quality

    Article • Journal of Oral Rehabilitation, April 2026, Wiley

    Takahiko Nagamine

  14. The objective imperative: advancing chronic orofacial pain research with the brain-heart axis

    Article • Exploration of Medicine, March 2026, Open Exploration Publishing

    Takahiko Nagamine

  15. Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate Therapy: Three Case Reports

    Article • American Journal of Therapeutics, March 2026, Wolters Kluwer Health

    Takahiko Nagamine

  16. Beyond Policy Interventions: Addressing the Persistence of Hypnotic Use and Polypharmacy in Japan's Aging Population

    Article • Geriatrics and Gerontology International, March 2026, Wiley

    Takahiko Nagamine

  17. Bridging Metabolomics and Nociception: The Arachidonic Acid–NMDA Receptor Axis in Burning Mouth Syndrome

    Article • Journal of Oral Rehabilitation, February 2026, Wiley

    Takahiko Nagamine

  18. Beyond Prescriptions: Addressing Stagnation in Benzodiazepine Reduction in Acute Care Geriatric Wards in Japan

    Article • Geriatrics and Gerontology International, February 2026, Wiley

    Takahiko Nagamine

  19. Tongue Pressure: A Critical Bridge Between Oral Frailty and Systemic Longevity in Older Adults

    Article • Geriatrics and Gerontology International, February 2026, Wiley

    Takahiko Nagamine

  20. Integrating a Biopsychosocial and Neuroscientific Perspective Into Satoyama‐Based Frailty Research

    Article • Geriatrics and Gerontology International, February 2026, Wiley

    Takahiko Nagamine

  21. Noise Pareidolia Test for Delirium Prediction: Considering the Role of Dopaminergic Basal Ganglia Circuitry

    Article • Geriatrics and Gerontology International, February 2026, Wiley

    Takahiko Nagamine

  22. Attention to Elderspeak: A Call for Dignity-Affirming Communication in Advanced Nursing Care

    Article • Clinics and Practice, January 2026, MDPI AG

    Takahiko Nagamine

  23. Effective Treatment With Olanzapine for Burning Mouth Syndrome With Denture Intolerance in an Older Patient: A Case Report

    Article • Gerodontology, January 2026, Wiley

    Takahiko Nagamine

  24. Neuroscience‐Based Nomenclature: Bridging the Knowledge Gap for Safer Medication Management in Older Adult Care

    Article • Psychogeriatrics, December 2025, Wiley

    Takahiko Nagamine

  25. The evolving serotonin syndrome spectrum: from acute syndrome to smoldering presentations and personalized risk management

    Article • Expert Opinion on Drug Metabolism & Toxicology, December 2025, Taylor & Francis

    Takahiko Nagamine

  26. Age, Sex, and Neuroinflammation: A Unified Mechanism for Burning Mouth Syndrome Driven by Small Fiber Neuropathy and Central Sensitization

    Article • Journal of Oral Pathology and Medicine, December 2025, Wiley

    Takahiko Nagamine

  27. A Pharmacological and Critical Review of Caffeine and Alpha‐Lipoic Acid for Burning Mouth Syndrome

    Article • Journal of Oral Rehabilitation, December 2025, Wiley

    Takahiko Nagamine

  28. Improving Communication With Older Adults Using a Self‐Reflection Questionnaire for Elderspeak: A Preliminary Proposal

    Article • Geriatrics and Gerontology International, December 2025, Wiley

    Takahiko Nagamine

  29. Managing Constipation in Older Adults on Atypical Antipsychotics: A Defecation Reflex and Gut Microbiota Approach

    Article • Psychogeriatrics, November 2025, Wiley

    Takahiko Nagamine

  30. The Oral–Brain Axis: A Novel Perspective on Bruxism and Orofacial Pain

    Article • Australian Dental Journal, September 2025, Wiley

    Takahiko Nagamine

  31. Bridging the Mind–Mouth Divide: Neuroscience's Essential Role in Dental Psychosomatic Education

    Article • Journal of Dental Education, September 2025, Wiley

    Takahiko Nagamine

  32. N-methyl-D-aspartate receptor as a therapeutic target for burning mouth syndrome

    Article • Expert Review of Clinical Pharmacology, September 2025, Taylor & Francis

    Takahiko Nagamine

  33. Beyond Tooth Count: The Interplay of Oral Health, Frailty and Falls

    Article • Journal of Oral Rehabilitation, September 2025, Wiley

    Takahiko Nagamine

  34. Burning Mouth Syndrome: A Neurological Reappraisal Through Idiopathic Intracranial Hypertension and Glymphatic Dysfunction

    Article • Journal of Oral Rehabilitation, September 2025, Wiley

    Takahiko Nagamine

  35. Rethinking Burning Mouth Syndrome: A Nociplastic Pain Disorder Shaped by Sexual Dimorphism

    Article • Oral Diseases, September 2025, Wiley

    Takahiko Nagamine

  36. Real-World Prescribing Patterns and Treatment Continuation of Amitriptyline Monotherapy and Aripiprazole Augmentation for Medically Unexplained Oral Symptoms/Syndromes in Japan

    Article • Pharmaceuticals, August 2025, MDPI AG

    Takahiko Nagamine

  37. Commentary on “Examining the combined effects of social isolation and oral dysfunction on cognitive decline in community‐dwelling older Japanese adults”: Proposing a vicious cycle and holistic interventions

    Article • Geriatrics and Gerontology International, August 2025, Wiley

    Takahiko Nagamine

  38. Role of Brain Networks in Burning Mouth Syndrome: A Narrative Review

    Article • Dentistry Journal, July 2025, MDPI AG

    Takahiko Nagamine

  39. Potential Target Receptors for the Pharmacotherapy of Burning Mouth Syndrome

    Article • Pharmaceuticals, June 2025, MDPI AG

    Takahiko Nagamine

  40. Memantine-Associated Decrease in Renal Function and Hyperuricemia

    Article • American Journal of Therapeutics, May 2025, Wolters Kluwer Health

    Takahiko Nagamine

  41. Estrogen-Mediated Neural Mechanisms of Sex Differences in Burning Mouth Syndrome

    Article • Neurology International, April 2025, MDPI AG

    Takahiko Nagamine

  42. Life-threatening Neuroleptic Malignant Syndrome and Its Mechanism

    Article • Internal Medicine, April 2025, Japanese Society of Internal Medicine

    Takahiko Nagamine

  43. Pathogenesis of Orofacial Pain Based on Brain Circuits

    Article • Oral Diseases, February 2025, Wiley

    Takahiko Nagamine

  44. Molecular Mechanisms of Pain Regulation by Sex Hormones in Individuals With Burning Mouth Syndrome

    Article • Journal of Oral Rehabilitation, February 2025, Wiley

    Takahiko Nagamine

  45. Challenges of Constipation in People Suffering from Schizophrenia: A Narrative Review

    Article • Clinics and Practice, February 2025, MDPI AG

    Takahiko Nagamine

  46. Perioperative administration of esketamine during cesarean section is a double-edged sword

    Article • Psychiatry Research, February 2025, Elsevier

    Takahiko Nagamine

  47. Application of virtual reality technology improves the functionality of brain networks in individuals experiencing pain

    Article • World Journal of Clinical Cases, January 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Takahiko Nagamine

  48. Investigating the Influence of Birth Month on the Incidence of Burning Mouth Syndrome

    Article • Oral Diseases, December 2024, Wiley

    Takahiko Nagamine

  49. Merits and demerits of administering esketamine in preventing postpartum depression following cesarean section

    Article • World Journal of Clinical Cases, December 2024, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Takahiko Nagamine

  50. Low‐dose amitriptyline: A potential therapeutic option for chronic pain in older people

    Article • British Journal of Clinical Pharmacology, December 2024, Wiley

    Takahiko Nagamine

  51. Facial aesthetics is shaped not only by genetic predispositions but also by the cultural norms and values

    Article • World Journal of Clinical Cases, December 2024, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Takahiko Nagamine

  52. The Role of the Gut Microbiota in Individuals with Irritable Bowel Syndrome: A Scoping Review

    Article • Medicina, November 2024, MDPI AG

    Takahiko Nagamine

  53. Mechanisms of Drug-Associated Burning Mouth Syndrome

    Article • Journal of Clinical Psychopharmacology, September 2024, Wolters Kluwer Health

    Takahiko Nagamine

  54. Suicidality in individuals experiencing chronic orofacial pain

    Article • Oral Diseases, August 2024, Wiley

    Takahiko Nagamine

  55. The role of oral microbiota in the pathogenesis of burning mouth syndrome

    Article • Oral Diseases, August 2024, Wiley

    Takahiko Nagamine

  56. Chronic orofacial pain

    Article • BDJ, August 2024, Springer Science + Business Media

    Takahiko Nagamine

  57. Responsiveness to amitriptyline in burning mouth syndrome

    Article • Gerodontology, June 2024, Wiley

    Takahiko Nagamine

  58. Amitriptyline at low dose for burning mouth syndrome

    Article • Oral Diseases, April 2024, Wiley

    Takahiko Nagamine

  59. The effective perospirone augmentation with clonazepam for treatment‐resistant burning mouth syndrome: A case report

    Article • Neuropsychopharmacology Reports, March 2024, Wiley

    Takahiko Nagamine

  60. Goal Attainment Scaling in Patients With Burning Mouth Syndrome: A Real-World Clinical Study Protocol

    Article • Cureus, February 2024, Springer Science + Business Media

    Takahiko Nagamine

  61. QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome

    Article • Clinical Neuropharmacology, January 2024, Wolters Kluwer Health

    Takahiko Nagamine

  62. Guanfacine Used With Antipsychotics May Cause Bradycardia to Become Apparent After Discontinuation of Antipsychotics

    Article • American Journal of Therapeutics, January 2024, Wolters Kluwer Health

    Takahiko Nagamine

  63. Spontaneous Pneumomediastinum in a Middle-Aged Female Patient With Schizophrenia: A Case Report

    Article • Cureus, January 2024, Springer Science + Business Media

    Takahiko Nagamine

  64. Leukopenia associated with lamotrigine initiation after COVID-19 vaccine booster: A case report and literature review

    Article • International Journal of Clinical Pharmacology and Therapeutics, January 2024, Dustri-Verlgag Dr. Karl Feistle

    Takahiko Nagamine

  65. Effect of magnesium oxide with probiotics on bowel movements in elderly orthopedic patients with chronic constipation: a retrospective chart review

    Article • Bioscience of Microbiota Food and Health, January 2024, BMFH Press

    Takahiko Nagamine

  66. Clinical Features and Variations of Pain Expressions in 834 Burning Mouth Syndrome Patients With or Without Psychiatric Comorbidities

    Article • Cureus, December 2023, Springer Science + Business Media

    Takahiko Nagamine

  67. Burning mouth syndrome needs to consider the gut-brain axis from three types of pain: nociceptive, neuropathic, and nociplastic pain

    Article • Journal of Gastrointestinal and Liver Diseases, December 2023, Romanian Society of Gastroenterology and Heptatology

    Takahiko Nagamine

  68. Poststroke Mania During the COVID-19 Pandemic

    Article • The Journal of Nervous and Mental Disease, December 2023, Wolters Kluwer Health

    Takahiko Nagamine

  69. Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion

    Article • Endocrine, November 2023, Springer Science + Business Media

    Takahiko Nagamine

  70. Beware of attention‐deficit/hyperactivity disorder (ADHD) in older adults

    Article • Psychogeriatrics, November 2023, Wiley

    Takahiko Nagamine

  71. Dental conditions in patients with medically unexplained oral symptoms

    Article • Journal of Dental Sciences, October 2023, Elsevier

    Takahiko Nagamine

  72. Sepsis associated with sodium glucose co‐transporter 2 inhibitor in an elderly patient with chronic kidney disease

    Article • Geriatrics and Gerontology International, September 2023, Wiley

    Takahiko Nagamine

  73. Comment on: The assessment of the long-term prognosis of burning mouth syndrome following treatment necessitates a reappraisal

    Article • International Journal of Oral and Maxillofacial Surgery, September 2023, Elsevier

    Takahiko Nagamine

  74. Letter to the Editor: Venous Neurovascular Compression and Chronic Orofacial Pain

    Article • World Neurosurgery, August 2023, Elsevier

    Takahiko Nagamine

  75. Antiviral Therapy for COVID-19 May Not Reduce Stroke Complications

    Article • Neurology India, July 2023, Medknow

    Takahiko Nagamine

  76. Preventing dehydration can help ensure safe use of psychotropic medications in the elderly

    Article • Psychogeriatrics, April 2023, Wiley

    Takahiko Nagamine

  77. Somatization and Medicalization in Patients with Unexplained Orofacial Pain

    Article • March 2023, IMR Press

    Takahiko Nagamine

  78. Case series of drug-induced open bite: Extrapyramidal symptoms related to psychotropic medications

    Article • Frontiers in Psychiatry, March 2023, Frontiers

    Takahiko Nagamine

  79. Serotonin Paradox in Burning Mouth Syndrome

    Article • Journal of Clinical Psychopharmacology, March 2023, Wolters Kluwer Health

    Takahiko Nagamine

  80. Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone

    Article • Clinical Psychopharmacology and Neuroscience, February 2023, Korean College of Neuropsychopharmacology (KAMJE)

    Takahiko Nagamine

  81. Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study

    Article • Pulmonary Pharmacology & Therapeutics, February 2023, Elsevier

    Takahiko Nagamine

  82. Omicron variant infections and multiple strokes in older adults

    Article • Geriatrics and Gerontology International, January 2023, Wiley

    Takahiko Nagamine

  83. Beware of bihemispheric stroke after Omicron variant infection in the elderly

    Article • Brain Circulation, January 2023, Medknow

    Takahiko Nagamine

  84. Clozapine-Induced Fever and Plasma Cytokine Changes in a Patient With Schizophrenia

    Article • Clinical Neuropharmacology, October 2022, Wolters Kluwer Health

    Takahiko Nagamine

  85. Two-hit theory by estrogen in burning mouth syndrome

    Article • Journal of Dental Sciences, October 2022, Elsevier

    Takahiko Nagamine

  86. Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist

    Article • Frontiers in Psychiatry, September 2022, Frontiers

    Takahiko Nagamine

  87. Duloxetine-induced Hyponatremia Can Occur in Not Only Syndrome of Inappropriate Secretion of Antidiuretic Hormone but Also Cerebral Salt Wasting Syndrome

    Article • Internal Medicine, July 2022, Japanese Society of Internal Medicine

    Takahiko Nagamine

  88. Factors associated with the frequency of respiratory rate measurement by hospital nurses: a multicentre cross-sectional study

    Article • British Journal of Nursing, May 2022, Mark Allen Group

    Atsushi Takayama, Takahiko Nagamine

  89. How to facilitate respiratory rate measurement in the emergency room

    Article • Japan Journal of Nursing Science, May 2022, Wiley

    Takahiko Nagamine

  90. Beware of serotonin syndrome during the COVID-19 pandemic

    Article • Australian & New Zealand Journal of Psychiatry, March 2022, SAGE Publications

    Takahiko Nagamine

  91. Beware of serotonin overload in pharmacotherapy for elderly patients with burning mouth syndrome

    Article • Psychogeriatrics, March 2022, Wiley

    Takahiko Nagamine

  92. The Effectiveness and Adverse Events of Amitriptyline and Aripiprazole in Very Elderly Patients With BMS

    Article • Frontiers in Pain Research, March 2022, Frontiers

    Takahiko Nagamine

  93. Neuroleptic malignant syndrome associated with COVID-19 vaccination

    Article • Canadian Journal of Emergency Medicine, December 2021, Springer Science + Business Media

    Takahiko Nagamine

  94. BRASH syndrome associated with angiotensin receptor blocker and SGLT2 inhibitor

    Article • Canadian Journal of Emergency Medicine, October 2021, Springer Science + Business Media

    Takahiko Nagamine

  95. Metabolic Effects of Clozapine Administration Based on Sex Differences and the Relationships Between Dosage and Prolactin Levels: An Observational Study

    Article • Clinical Neuropharmacology, September 2021, Wolters Kluwer Health

    Takahiko Nagamine

  96. Foreign accent syndrome associated with left insula infarction after COVID-19 pneumonia

    Article • Canadian Journal of Emergency Medicine, August 2021, Springer Science + Business Media

    Takahiko Nagamine

  97. Beware of Biphasic Anaphylaxis

    Article • Journal of Emergency Medicine, August 2021, Elsevier

    Takahiko Nagamine

  98. Biliary pseudolithiasis in an older patient treated with lascufloxacin

    Article • Geriatrics and Gerontology International, June 2021, Wiley

    Takahiko Nagamine

  99. Beware of traumatic anosmia in COVID-19 pandemic

    Article • Canadian Journal of Emergency Medicine, April 2021, Springer Science + Business Media

    Takahiko Nagamine

  100. Long‐term preoperative use of zolpidem is associated with postoperative delirium in elderly patients undergoing hip surgery

    Article • Psychogeriatrics, April 2021, Wiley

    Takahiko Nagamine

  101. Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study

    Article • International Clinical Psychopharmacology, March 2021, Wolters Kluwer Health

    Takahiko Nagamine

  102. Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment

    Article • Oral Diseases, January 2021, Wiley

    Takahiko Nagamine

  103. Atypical diabetes mellitus caused by olanzapine

    Article • Australian & New Zealand Journal of Psychiatry, January 2021, SAGE Publications

    Takahiko Nagamine

  104. Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes

    Article • eLife, November 2020, eLife

    Takahiko Nagamine

  105. Severe hypoglycemia in an elderly patient with Alzheimer's disease and with sepsis: The role of neurotransmitters on glucose regulation

    Article • Geriatrics and Gerontology International, November 2020, Wiley

    Takahiko Nagamine

  106. Cognitive decline due to the cerebral cavernous malformations

    Article • Australian & New Zealand Journal of Psychiatry, August 2020, SAGE Publications

    Takahiko Nagamine

  107. Reply to the comments on “Aging is independently associated with an increasing normal respiratory rate among older adults without pulmonary disease and chronic heart failure”

    Article • Geriatrics and Gerontology International, May 2020, Wiley

    Takahiko Nagamine

  108. Eosinophilic pneumonia during treatment with clozapine: reports from a retrospective case series

    Article • International Clinical Psychopharmacology, April 2020, Wolters Kluwer Health

    Takahiko Nagamine

  109. Contrasting characters of quick methods to measure respiratory rate in a clinical setting

    Article • The Clinical Respiratory Journal, March 2020, Wiley

    Takahiko Nagamine

  110. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease

    Article • Asian Journal of Psychiatry, March 2020, Elsevier

    Takahiko Nagamine

  111. The effect of probiotics on bowel movement and metabolic parameters in schizophrenia patients: a retrospective chart review

    Article • Bioscience of Microbiota Food and Health, January 2020, BMFH Press

    Takahiko Nagamine

  112. Correspondence- ‘Role of Diffusion Weighted Imaging in Differentiating Benign from Pathological Vertebral Collapse using ADC Values’; Is It Possible to Discriminate Multiple Myeloma with Magnetic Resonance Imaging?

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2020, JCDR Research and Publications

    Takahiko Nagamine

  113. Correspondence: Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient’s Outcome in Severe Traumatic Brain Injury

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2020, JCDR Research and Publications

    Takahiko Nagamine

  114. Letter Regarding the Article, ‘Hyponatremia in Patients Admitted with Stroke’; From the Viewpoint of Similarity to Hyponatremia Associated with Traumatic Brain Injury

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2020, JCDR Research and Publications

    Takahiko Nagamine

  115. Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome

    Article • December 2019, Taylor & Francis

    Prof. Akira Toyofuku, Takahiko Nagamine, TAKAYUKI SUGA

  116. Acute psychosis secondary to atypical Bickerstaff brainstem encephalitis

    Article • Asian Journal of Psychiatry, December 2019, Elsevier

    Takahiko Nagamine

  117. Aging is independently associated with an increasing normal respiratory rate among an older adult population in a clinical setting: A cross‐sectional study

    Article • Geriatrics and Gerontology International, October 2019, Wiley

    Takahiko Nagamine

  118. Primary prevention of Clostridioides difficile infection with combination probiotics

    Article • Journal of Hospital Infection, October 2019, Elsevier

    Takahiko Nagamine

  119. Recurrence of eosinophilic pneumonia after clozapine treatment

    Article • Asian Journal of Psychiatry, August 2019, Elsevier

    Takahiko Nagamine

  120. Duloxetine and Angiotensin II Receptor Blocker Combination Potentially Induce Severe Hyponatremia in an Elderly Woman

    Article • Internal Medicine, June 2019, Japanese Society of Internal Medicine

    Takahiko Nagamine

  121. A Comparison of Methods to Count Breathing Frequency

    Article • Respiratory Care, April 2019, Daedalus Enterprises

    Takahiko Nagamine

  122. Letter to the Editor on ‘PCR as a Diagnostic Tool for Extra-Pulmonary Tuberculosis’

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2019, JCDR Research and Publications

    Takahiko Nagamine

  123. Is primary prevention of Clostridioides difficile infection possible with combination probiotics in elderly orthopedic patients?

    Article • Bioscience of Microbiota Food and Health, January 2019, BMFH Press

    Takahiko Nagamine

  124. Correspondence: ‘Influenza as a Cause of SIADH Related Hyponatremia’

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2019, JCDR Research and Publications

    Takahiko Nagamine

  125. Combination probiotics may prevent Clostridium difficile infection among elderly patients undergoing an orthopedic surgery

    Article • Bioscience of Microbiota Food and Health, January 2019, BMFH Press

    Takahiko Nagamine

  126. Correspondence: Curious Case of Myocardial Infarction Caused by Lung Abscess- From the Viewpoint of Type 2 Myocardial Infarction by Chest Trauma

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2019, JCDR Research and Publications

    Takahiko Nagamine

  127. Burning mouth syndrome: The challenge of an aging population

    Article • Geriatrics and Gerontology International, December 2018, Wiley

    Takahiko Nagamine

  128. Serum electrolyte levels may be associated with prefrontal hemodynamic responses in near infrared spectroscopy

    Article • Journal of Near Infrared Spectroscopy, July 2018, SAGE Publications

    Masaru Nakamura, Takahiko Nagamine

  129. An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome

    Article • Asia-Pacific Psychiatry, March 2018, Wiley

    Takahiko Nagamine

  130. Serum prolactin levels are associated with prefrontal hemodynamic responses using near-infrared spectroscopy in male psychotic patients treated with antipsychotics

    Article • Psychiatry and Clinical Neurosciences, March 2018, Wiley

    Takahiko Nagamine

  131. Serum prolactin levels might become a useful marker for switching strategy to paliperidone palmitate in male schizophrenia patient

    Article • Asia-Pacific Psychiatry, January 2018, Wiley

    Takahiko Nagamine

  132. 4G-β-D-galactosylsucrose as a prebiotics may improve underweight in inpatients with schizophrenia

    Article • Bioscience of Microbiota Food and Health, January 2018, BMFH Press

    Takahiko Nagamine

  133. The QTc shortening with amitriptyline may indicate treatment resistance in chronic nonorganic orofacial pain

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2018, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  134. Adrenaline reversal may be an unwarranted distraction during emergency cardiovascular care for patients treated with antipsychotics

    Article • Asia-Pacific Psychiatry, December 2017, Wiley

    Takahiko Nagamine

  135. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain

    Article • Psychiatry and Clinical Neurosciences, November 2017, Wiley

    Takahiko Nagamine

  136. Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia

    Article • Psychiatry and Clinical Neurosciences, November 2017, Wiley

    Takahiko Nagamine

  137. Carnitine may prevent health problems in hyperprolactinemia

    Article • Psychiatry and Clinical Neurosciences, July 2017, Wiley

    Takahiko Nagamine

  138. antipsychotic-induced hypoglycemia

    Article • Psychiatry and Clinical Neurosciences, July 2016, Wiley

    Takahiko Nagamine

  139. Iron Depletion Affects Dopamine Neurotransmissions

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2016, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  140. Cerebral edema secondary to psychogenic polydipsia induced by tandospirone as add-on to olanzapine therapy

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2014, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  141. Does olanzapine impair pancreatic beta-cell function directly?

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2014, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  142. Olanzapine-induced severe hyperglycemia was completely reversed by the restoration of insulin secretion after switching to aripiprazole and initiating insulin therapy

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2014, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  143. Erratum: Riwa Ozasa, Tetsuya Okada, Satomi Nadanaka, Takahiko Nagamine, Alisha Zyryanova, Heather Harding, David Ron, Kazutoshi Mori (2013) The Antipsychotic Olanzapine Induces Apoptosis in Insulin-secreting Pancreatic ^|^beta; Cells by Blocking PERK-m...

    Article • Cell Structure and Function, January 2013, Japan Society for Cell Biology

    Takahiko Nagamine

  144. The Antipsychotic Olanzapine Induces Apoptosis in Insulin-secreting Pancreatic β Cells by Blocking PERK-mediated Translational Attenuation

    Article • Cell Structure and Function, January 2013, Japan Society for Cell Biology

    Takahiko Nagamine

  145. Lithium Intoxication Associated with Angiotensin II Type 1 Receptor Blockers in Women

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2013, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  146. Metabolic Effects of Sodium Valproate on Atypical Antipsychotics in Japanese Psychotic Patients

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2013, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  147. Antipsychotic-induced hyperthermia in patients with behavioral and psychological symptoms of dementia

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2012, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  148. Are psychotropic drugs involved in gallstone-induced acute abdomen in inpatients with schizophrenia?

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2012, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  149. Carnitine Deficiency and Severe Hypoglycemia Associated with Valproic Acid

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2012, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  150. Duloxetine-induced Hyponatremia in the Elderly

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2012, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  151. Hypoprolactinemia and Extrapyramidal Symptoms in Male Schizophrenia or Psychotic Affective Disorder Patients Treated with Aripiprazole

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2012, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  152. Metabolic Effects of Valproic Acid Augmentation in Male Schizophrenic Patients

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2012, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  153. Are combination therapies with aripiprazole and other antipsychotics pharmacologically rational?

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2011, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  154. What does antipsychotic-associated hypoprolactinemia mean in patients with chronic schizophrenia?

    Article • Clinical Neuropsychopharmacology and Therapeutics, January 2011, The Japanese Society of Clinical Neuropsychopharmacology

    Takahiko Nagamine

  155. Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study

    Article • Neuropsychiatric Disease and Treatment, June 2010, Taylor & Francis

    Dr Mike Briley, Takahiko Nagamine

  156. Severe Hyperglycemia Induced by Olanzapine was Improved with a Recovery of Insulin Secretion after Switching to Risperidone and Introducing Insulin Therapy

    Article • Internal Medicine, January 2010, Japanese Society of Internal Medicine

    Takahiko Nagamine

  157. Olanzapine-induced Elevation of Serum Triglyceride Levels in a Normal Weight Patient with Schizophrenia

    Article • Internal Medicine, January 2008, Japanese Society of Internal Medicine

    Takahiko Nagamine

  158. Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients

    Article • Neuropsychiatric Disease and Treatment, February 2007, Taylor & Francis

    Takahiko Nagamine

  159. Hypoglycemia associated with insulin hypersecretion following the addition of olanzapine to conventional antipsychotics

    Article • Neuropsychiatric Disease and Treatment, December 2006, Taylor & Francis

    Takahiko Nagamine

  160. Attitudes toward death in rural areas of Japan

    Article • Death Studies, January 1988, Taylor & Francis

    Takahiko Nagamine